3
Announcements
Trials
Browse
Landscape
Status
Recruiting
5
Active not recruiting
3
Withdrawn
1
Terminated
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
6
Lung Neoplasms
6
Prostatic Neoplasms
5
Breast Neoplasms
5
Multiple Myeloma
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Ovarian Neoplasms
3
Osteosarcoma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Barrett Esophagus
3
Urinary Bladder Neoplasms
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Leukemia, Biphenotypic, Acute
2
Gastroesophageal Reflux
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Adenocarcinoma Of Esophagus
2
Wilms Tumor
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urethral Neoplasms
1
Interventions
Fluorouracil
155
Oxaliplatin
133
Leucovorin
124
Capecitabine
90
Irinotecan
88
Radiotherapy
63
Bevacizumab
61
Cetuximab
38
Folfox protocol
25
Panitumumab
21
Neoadjuvant Therapy
21
Surgical Procedures, Operative
19
Chemotherapy, Adjuvant
15
Radiation
13
Floxuridine
13
Erlotinib Hydrochloride
13
Early Intervention, Educational
13
IFL protocol
11
Drug Therapy
11
Proctectomy
10
Magnetic Resonance Spectroscopy
10
Counseling
10
Surveys and Questionnaires
8
Sorafenib
8
Psychiatric Rehabilitation
8
Gene Expression Profiling
8
Radiotherapy, Intensity-Modulated
7
Immunohistochemistry
7
Gemcitabine
7
Celecoxib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Rectal Neoplasms
×
Specimen Handling
×
Clear all
NCT02243267
2017-11-08
GI SPORE Colon Biosample Protocol
University of Michigan
Completed
115 enrolled